炎症性关节病患者与无炎症性关节病患者的心肌梗死特征及短期结局相似:一项挪威全国性研究
该研究基于挪威全国心肌梗死登记数据,纳入2013年1月至2017年12月首次心肌梗死且既往无动脉粥样硬化性心血管疾病的患者,比较类风湿关节炎、中轴型脊柱关节炎和银屑病关节炎患者与无炎症性关节病个体在症状、心肌损伤、急性治疗、院内不良事件、短期结局及二级预防药物上的差异。结果显示各组表现和短期结局相似或炎症性关节病组更优,作者认为这可为炎症性关节病患者心肌梗死后的短期预后提供安心依据。
要点
- 胸痛是所有组最常见症状,炎症性关节病亚组未见非典型表现更多。
- ST段抬高型心肌梗死率、肌钙蛋白T水平和多支病变在炎症性关节病组未更差。
- 院内不良事件和短期死亡率在炎症性关节病亚组相似或更低。
核心结论
- 类风湿关节炎、中轴型脊柱关节炎和银屑病关节炎患者的心肌梗死表现、病程和短期结局与无炎症性关节病者相当。
- 作者认为这些发现可为炎症性关节病患者发生心肌梗死后的短期预后提供安心依据。
研究设计与样本
- 基于挪威全国心肌梗死登记数据的注册研究,覆盖2013年1月至2017年12月首次心肌梗死且既往无已知动脉粥样硬化性心血管疾病的成人。
- 队列包括981例类风湿关节炎、314例中轴型脊柱关节炎、434例银屑病关节炎患者和34783例无炎症性关节病个体。
- 采用逻辑回归和广义线性模型,在按性别分层的年龄校正模型中比较炎症性关节病组与非炎症性关节病组。
主要发现
- 胸痛是所有组最常见症状,无迹象表明炎症性关节病亚组比无炎症性关节病者更常出现非典型表现。
- ST段抬高型心肌梗死率、肌钙蛋白T水平和多支病变等心肌损伤指标在炎症性关节病患者中未更差。
- 炎症性关节病患者接受急性治疗的比例等于或高于无炎症性关节病个体。
- 所有院内不良事件和短期死亡率在炎症性关节病亚组中与无炎症性关节病者相似或更低。
- 无任何二级心血管预防药物在炎症性关节病患者中的处方频率低于无炎症性关节病者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare presenting symptoms, myocardial damage, acute treatment, in-hospital adverse events, short-term outcomes and secondary cardio-preventive drugs in patients with rheumatoid arthritis, axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) experiencing their first myocardial infarction (MI) versus patients without inflammatory joint diseases (IJD). METHODS: We analyzed register data covering the entire adult Norwegian population, examining individuals experiencing their first MI, sourced from the Norwegian MI register between January 2013 and December 2017. Only patients without known atherosclerotic cardiovascular disease were analyzed. Outcomes were compared between IJD and non-IJD groups using logistic regression and generalized linear models, in age-adjusted models stratified by sex. RESULTS: Our cohort included 981 RA patients, 314 axSpA patients, 434 PsA patients and 34,783 non-IJD individuals experiencing a first MI. Chest pain was the most common symptom in all groups, and there was no indication that IJD subgroups experienced atypical presentations more often than non-IJD. Myocardial damage indicators - ST-elevation MI rates, troponin T levels and multi-vessel disease - were not worse in IJD patients. Acute treatments were equally, or more, often performed in IJD compared to non-IJD individuals. All in-hospital adverse events and short-term mortality were similar or less common in the IJD subgroups compared to non-IJD patients. None of the secondary cardio-preventive drugs were prescribed less frequently to IJD patients than to non-IJD. CONCLUSION: RA, axSpA and PsA patients showed comparable MI presentations, disease courses and short-term outcomes to those without IJD. These findings should provide reassurance about the short-term prognosis of IJD patients experiencing MI.
引用
- Ikdahl E, Kerola A, Myhre PPL, et al. Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: A nationwide Norwegian study. Semin Arthritis Rheum. 2025. PMID: 40479774. doi:10.1016/j.semarthrit.2025.152760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。